Joined QIAGEN in 2005 as part of the acquisition of Nextal Biotechnologies Inc., a provider of technologies for protein crystallization where he served as President and CEO. He has served since 2023 as Senior Vice President, Corporate Strategy and Business Development. Prior to that, he served since 2020 as Senior Vice President, Head of Molecular Diagnostics Business Area, which involves QIAGEN’s activities supporting customers in clinical healthcare. He has been a member of the Executive Committee since 2019. He earned a Bachelor’s degree in Biochemistry from the University of Montreal, Canada.